Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

The 1st Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning

Press Release

July 26, 2022, from 3pm to 5pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

Agenda
  1. Introduction of the Subcommittee Members
  2. About the Science Board
  3. Purpose, Work and Schedule for the Subcommittee
    • About Subcommittee on Software as a Medical Device utilizing AI (Professor SAKUMA, Chairperson of the Subcommittee)
  4. Lectures on Software as a Medical Device Utilizing AI and Discussion
    • Review of Machine Learning-enabled Medical Devices (Office of Software as a Medical Device)
    • Summary of study on appropriate framework for regulating software as medical devices (SaMD) using innovative technologies including artificial intelligence/machine learning (Dr. NAKAOKA)
  5. Others
 
List of Handouts 
  • Document 1     Member List of the Subcommittee
  • Document 2     About the Science Board
  • Document 3     Lecture Materials by Professor SAKUMA, Chairperson of the Subcommitte
  • Document 4     Lecture Materials by Office of Software as a Medical Device
  • Document 5     Lecture Materials by Dr. NAKAOKA
  • Ref.1                PMDA Science Board Rules
  • Ref.2                PMDA Science Board Subcommittee Rules
  • Ref.3                Rules for Commissioning Members of the Science Board and the Subcommittees
  • Ref.4                Memorandum of Understanding on Disclosure of Minutes and Handouts
  • Ref.5                Memorandum of Understanding for Requesting Attendance of External Experts
  • Ref.6                Memorandum of Understanding on Management of Working Group